Svati Shah, MD, associate dean for genomics and professor of medicine, received the Genomic and Precision Medicine Mentoring Award from the American Heart Association.
A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.
School of Medicine students featured in the Graduates School's 2022 Snapshots
Like many Americans, the murder of George Floyd in 2020 was a wake-up call for Taylor Abele, a PhD student in the Department of Immunology. Not only did the horrific event motivate her to get more involved in changing systems that lead to inequalities, but it also provided her with the courage to stand up for herself and other LGBTQ+ individuals.
Dr. Tim Hammond, professor of medicine at Duke, and co-investigator Dr. Holly Birdsall created the “Fuel to Mars” study to identify genes and gene pathways that fuel-producing algae use to survive deep space.
Priya Kishnani, MD, MBBS, Chen Family Distinguished Professor of Pediatrics and chief of the Division of Medical Genetics at the Duke University School of Medicine, received one of North Carolina’s highest civilian honors, the North Carolina Award for her contributions to science.
Thirty Duke scientists — including no fewer than 21 with appointments in the School of Medicine — are on Clarivate's global Most Cited Scientists list, which tracks researchers whose publications are among the top 1 percent of citations in their field.
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.
Led by three families who mobilized their personal networks and ultimately generated support from more than 500 donors, the Duke ALS community raised $3.5 million to establish the Stewart, Hughes, and Wendt Endowed Professorship in the Department of Neurology.
Non-Hispanic Black patients are less likely to receive guideline-appropriate treatment for ovarian cancer than non-Hispanic White patients, significantly affecting their treatment quality and survival chances.